TY  - JOUR 
AU  - Ibáñez Fonseca, Arturo
AU  - Rico, Ana
AU  - Preciado, Silvia
AU  - González Pérez, Fernando
AU  - Muntión, Sandra
AU  - García Briñón, Jesús
AU  - García Macías, María Carmen
AU  - Rodríguez Cabello, José Carlos
AU  - Pericacho, Miguel
AU  - Alonso Rodrigo, Matilde
AU  - Sánchez Guijo, Fermín
PY  - 2022
SN  - 2296-4185
UR  - https://uvadoc.uva.es/handle/10324/55057
AB  - Hindlimb ischemia is an unmet medical need, especially for those patients unable to undergo vascular surgery. Cellular therapy, mainly through mesenchymal stromal cell (MSC) administration, may be a potentially attractive approach in this setting. In...
LA  - eng
PB  - Frontiers Media
KW  - Células
KW  - Isquemia
KW  - Medicina regenerativa
KW  - Mesenchymal stromal cells
KW  - Células estromales mesenquimales
KW  - Biomaterials
KW  - Biomateriales
KW  - Angiogenesis
TI  - Mesenchymal stromal cells combined with elastin-like recombinamers increase angiogenesis in vivo after hindlimb ischemia
DO  - 10.3389/fbioe.2022.918602
ER  -